+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Exoskeleton Market to 2027 - Global Analysis and Forecasts By Drive Type; Type; Extremity; Application; End User, and Geography

  • PDF Icon

    Report

  • 195 Pages
  • July 2019
  • Region: Global
  • The Insight Partners
  • ID: 4825249
UP TO OFF until Jun 30th 2024
The global medical exoskeleton market is expected to reach US$ 1,023.0 Mn in 2027 from US$ 96.7 Mn in 2018. The Medical Exoskeleton market is estimated to grow with a CAGR of 29.4% from 2019-2027.

The market is driven by the factors such as, increase in the number of orthopaedic surgeries, rise in the geriatric population and growing incidences of road accidents. However, the factor such as high cost of the product and regulatory concerns are likely to act as challenges for the growth of the market during the forecast period.

A geriatric population is a group of people who are of the age group of 65 years and above. The geriatric population across the world is rising due to the increase in life expectancy, developments in the healthcare systems, and increasing facilities and services across the globe. Therefore, the number of geriatric population has been overgrowing across the globe. Also, an aging population is poised to become one of the most significant social transformations of the twenty-first century.

According to the report ‘Aging in the United States’, revealed that the growing population (people 65 and older) is likely to reshape the scenario for the older people in America.

Similarly, the latest data published by the World Health Organization (WHO) in February 2018 says that in between 2015–2025 the world's population over 60 years is likely to increase roughly from 12% to 22%. Also, the pace of the geriatric population is growing much faster as compared to the past. Additionally, countries across the world are facing significant challenges, and trying to ensure their health and social systems are ready to accept most of the demographic shift.

The data by the WHO also estimated that until 2050, there would be approximately 120 million people living in China. Moreover, it is expected that near around 434 million people in the age group of 80 and above will be present across the world. Furthermore, it stated that by 2050, 80% of all older people would be registered in low and middle-income countries. The rise in the geriatric population has been observed across the world, for instance, France had almost taken 150 years to adapt the shift in the portion from 10% to 20% of the population which were older than 60 years. However, countries such as Brazil, China, and India will be experiencing a slight change, which will be more than 20 years to make the same adaptation.

Global medical exoskeleton market was segmented by drive type, type, extremity, application and end user. On the basis of the drive type the market is segmented as pneumatic actuator, hydraulic actuator, electric actuator, mechanical, shape memory alloy actuator, other actuator. Based on the type the medical exoskeleton market is segmented into powered exoskeleton, passive exoskeleton); extremity (lower body exoskeleton, upper body exoskeleton. Based on the application the market was segmented into spinal cord injury, multiple sclerosis, cerebral palsy, stroke and others. On the basis of the end user the market was segmented as rehabilitation centers, physiotherapy centers, physiotherapy centers, and others.

Some of the major primary and secondary sources included in the report for the medical exoskeleton market are Canadian Agency for Drugs and Technologies in Health, Centers for Disease Control and Prevention, European Committee for Standardization, Food and Drug Administration and others.

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Medical Exoskeleton Market – By Drive Type
1.3.2 Global Medical Exoskeleton Market – By Type
1.3.3 Global Medical Exoskeleton Market – By Extremity
1.3.4 Global Medical Exoskeleton Market – By Application
1.3.5 Global Medical Exoskeleton Market – By End User
1.3.6 Global Medical Exoskeleton Market – By Geography
2. Global Medical Exoskeleton Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Medical Exoskeleton– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Global Medical Exoskeleton Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increase In The Number of Orthopaedic Surgeries
5.1.2 Rise In The Geriatric Population
5.1.3 Growing Incidents Of Road Accidents
5.2 Key Market Challenge
5.2.1 High Cost Of The Products And Regulatory Concerns
5.3 Key Market Opportunities
5.3.1 High Market Potential In Developing Nations
5.3.2 Obesity, Chronic Disease and Osteoarthritis On The Rise
5.4 Future Trends
5.4.1 Demand For Higher Quality Products
5.5 Impact Analysis of Drivers and Challenges
6. Medical Exoskeleton Market – Global Analysis
6.1 Global Medical Exoskeleton Market Revenue Forecasts And Analysis
6.2 Global Medical Exoskeleton Market, By Geography - Forecasts And Analysis
6.3 Market Positioning Of Key Players
7. Medical Exoskeleton Market Analysis And Forecasts To 2027 – Drive Type
7.1 Overview
7.2 Global Medical Exoskeleton Market Share by Drive Type 2018 & 2027 (%)
7.3 Pneumatic Actuator
7.3.1 Overview
7.3.2 Pneumatic Actuator Market Revenue and Forecast to 2027 (US$ ‘000)
7.4 Hydraulic Actuator
7.4.1 Overview
7.4.2 Hydraulic Actuator Market Revenue and Forecast to 2027 (US$ ‘000)
7.5 Electric Actuator
7.5.1 Overview
7.5.2 Electric Actuator Market Revenue and Forecast to 2027 (US$ ‘000)
7.6 Mechanical
7.6.1 Overview
7.6.2 Mechanical Market Revenue and Forecast to 2027 (US$ ‘000)
7.7 Shape Memory Alloy Actuator
7.7.1 Overview
7.7.2 Shape Memory Alloy Actuator Market Revenue and Forecast to 2027 (US$ ‘000)
7.8 Other Actuator
7.8.1 Overview
7.8.2 Other Actuator Market Revenue and Forecast to 2027 (US$ ‘000)
8. Medical Exoskeleton Market Analysis And Forecasts To 2027 – Type
8.1 Overview
8.2 Global Medical Exoskeleton Market Share by Type 2018 & 2027 (%)
8.3 Powered Exoskeleton
8.3.1 Overview
8.3.2 Powered Exoskeleton Market Revenue and Forecast to 2027 (US$ ‘000)
8.4 Passive Exoskeleton
8.4.1 Overview
8.4.2 Passive Exoskeleton Market Revenue and Forecast to 2027 (US$ ‘000)
9. Medical Exoskeleton Market Analysis And Forecasts To 2027 – Extremity
9.1 Overview
9.2 Global Medical Exoskeleton Market Share by Extremity 2018 & 2027 (%)
9.3 Lower Body Exoskeleton
9.3.1 Overview
9.3.2 Lower Body Exoskeleton Market Revenue and Forecast to 2027 (US$ ‘000)
9.4 Upper Body Exoskeleton
9.4.1 Overview
9.4.2 Upper Body Exoskeleton Market Revenue and Forecast to 2027 (US$ ‘000)
10. Medical Exoskeleton Market Analysis And Forecasts To 2027 – Application
10.1 Overview
10.2 Global Medical Exoskeleton Market Share by Application 2018 & 2027 (%)
10.3 Spinal Cord Injury
10.3.1 Overview
10.3.2 Spinal Cord Injury Market Revenue and Forecast to 2027 (US$ ‘000)
10.4 Multiple Sclerosis
10.4.1 Overview
10.4.2 Multiple Sclerosis Market Revenue and Forecast to 2027 (US$ ‘000)
10.5 Cerebral Palsy
10.5.1 Overview
10.5.2 Cerebral Palsy Market Revenue and Forecast to 2027 (US$ ‘000)
10.6 Stroke
10.6.1 Overview
10.6.2 Stroke Market Revenue and Forecast to 2027 (US$ ‘000)
10.7 Others
10.7.1 Overview
10.7.2 Others Market Revenue and Forecast to 2027 (US$ ‘000)
11. Medical Exoskeleton Market Analysis And Forecasts To 2027 – End User
11.1 Overview
11.2 Global Medical Exoskeleton Market Share by End User 2018 & 2027 (%)
11.3 Rehabilitation Centers
11.3.1 Overview
11.3.2 Rehabilitation Centers Market Revenue and Forecast to 2027 (US$ ‘000)
11.4 Physiotherapy Centers
11.4.1 Overview
11.4.2 Physiotherapy Centers Market Revenue and Forecast to 2027 (US$ ‘000)
11.5 Others
11.5.1 Overview
11.5.2 Others Market Revenue and Forecast to 2027 (US$ ‘000)
12. Medical Exoskeleton Market Revenue And Forecasts To 2027 – Regional Analysis
12.1 North America Medical Exoskeleton Market
12.1.1 Overview
12.1.2 North America Medical Exoskeleton Market Revenue And Forecasts to 2027 (US$ ‘000)
12.1.3 North America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.1.4 North America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.1.5 North America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.1.6 North America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.1.7 North America Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.1.8 North America Medical Exoskeleton Market Revenue and Forecasts to 2027, By Country (%)
12.1.9 US Medical Exoskeleton Market
12.1.9.1 US Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.1.9.2 US Number of Rehabilitation Centers
12.1.9.3 US Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.1.9.4 US Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.1.9.5 US Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.1.9.6 US Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.1.9.7 US Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.1.10 Canada Medical Exoskeleton Market
12.1.10.1 Canada Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.1.10.2 Canada Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.1.10.3 Canada Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.1.10.4 Canada Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.1.10.5 Canada Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.1.10.6 Canada Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.1.11 Mexico Medical Exoskeleton Market
12.1.11.1 Mexico Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.1.11.2 Mexico Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.1.11.3 Mexico Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.1.11.4 Mexico Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.1.11.5 Mexico Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.1.11.6 Mexico Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.2 Europe Medical Exoskeleton Market
12.2.1 Overview
12.2.2 Europe Medical Exoskeleton Market Revenue And Forecasts to 2027 (US$ ‘000)
12.2.3 Europe Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.2.4 Europe Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.2.5 Europe Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.2.6 Europe Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.2.7 Europe Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.2.8 Europe Medical Exoskeleton Market Revenue and Forecasts to 2027, By Country (%)
12.2.9 UK Medical Exoskeleton Market
12.2.9.1 UK Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.2.9.2 UK Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.2.9.3 UK Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.2.9.4 UK Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.2.9.5 UK Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.2.9.6 UK Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.2.10 Germany Medical Exoskeleton Market
12.2.10.1 Germany Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.2.10.2 Germany Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.2.10.3 Germany Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.2.10.4 Germany Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.2.10.5 Germany Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.2.10.6 Germany Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.2.11 France Medical Exoskeleton Market
12.2.11.1 France Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.2.11.2 France Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.2.11.3 France Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.2.11.4 France Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.2.11.5 France Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.2.11.6 France Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.2.12 Spain Medical Exoskeleton Market
12.2.12.1 Spain Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.2.12.2 Spain Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.2.12.3 Spain Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.2.12.4 Spain Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.2.12.5 Spain Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.2.12.6 Spain Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.2.13 Italy Medical Exoskeleton Market
12.2.13.1 Italy Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.2.13.2 Italy Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.2.13.3 Italy Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.2.13.4 Italy Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.2.13.5 Italy Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.2.13.6 Italy Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.3 Asia Pacific Medical Exoskeleton Market
12.3.1 Overview
12.3.2 Asia Pacific Medical Exoskeleton Market Revenue And Forecasts to 2027 (US$ ‘000)
12.3.3 Asia Pacific Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.3.4 Asia Pacific Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.3.5 Asia Pacific Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.3.6 Asia Pacific Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.3.7 Asia Pacific Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.3.8 Asia Pacific Medical Exoskeleton Market Revenue and Forecasts to 2027, By Country (%)
12.3.9 China Medical Exoskeleton Market
12.3.9.1 China Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.3.9.2 China Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.3.9.3 China Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.3.9.4 China Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.3.9.5 China Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.3.9.6 China Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.3.10 Japan Medical Exoskeleton Market
12.3.10.1 Japan Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.3.10.2 Japan Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.3.10.3 Japan Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.3.10.4 Japan Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.3.10.5 Japan Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.3.10.6 Japan Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.3.11 India Medical Exoskeleton Market
12.3.11.1 India Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.3.11.2 India Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.3.11.3 India Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.3.11.4 India Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.3.11.5 India Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.3.11.6 India Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.3.12 Australia Medical Exoskeleton Market
12.3.12.1 Australia Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.3.12.2 Australia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.3.12.3 Australia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.3.12.4 Australia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.3.12.5 Australia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.3.12.6 Australia Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.3.13 South Korea Medical Exoskeleton Market
12.3.13.1 South Korea Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.3.13.2 South Korea Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.3.13.3 South Korea Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.3.13.4 South Korea Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.3.13.5 South Korea Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.3.13.6 South Korea Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.4 Middle East & Africa Medical Exoskeleton Market
12.4.1 Overview
12.4.2 Middle East & Africa Medical Exoskeleton Market Revenue And Forecasts to 2027 (US$ ‘000)
12.4.3 Middle East & Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.4.4 Middle East & Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.4.5 Middle East & Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.4.6 Middle East & Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.4.7 Middle East & Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.4.8 Middle East & Africa Medical Exoskeleton Market Revenue and Forecasts to 2027, By Country (%)
12.4.9 UAE Medical Exoskeleton Market
12.4.9.1 UAE Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.4.9.2 UAE Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.4.9.3 UAE Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.4.9.4 UAE Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.4.9.5 UAE Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.4.9.6 UAE Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.4.10 Saudi Arabia Medical Exoskeleton Market
12.4.10.1 Saudi Arabia Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.4.10.2 Saudi Arabia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.4.10.3 Saudi Arabia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.4.10.4 Saudi Arabia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.4.10.5 Saudi Arabia Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.4.10.6 Saudi Arabia Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.4.11 South Africa Medical Exoskeleton Market
12.4.11.1 South Africa Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.4.11.2 South Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.4.11.3 South Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.4.11.4 South Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.4.11.5 South Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.4.11.6 South Africa Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.5 South and Central America Medical Exoskeleton Market
12.5.1 Overview
12.5.2 South and Central America Medical Exoskeleton Market Revenue And Forecasts to 2027 (US$ ‘000)
12.5.3 South and Central America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.5.4 South and Central America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.5.5 South and Central America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.5.6 South and Central America Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.5.7 South and Central America Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.5.8 South and Central America Medical Exoskeleton Market Revenue and Forecasts to 2027, By Country (%)
12.5.9 Brazil Medical Exoskeleton Market
12.5.9.1 Brazil Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.5.9.2 Brazil Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.5.9.3 Brazil Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.5.9.4 Brazil Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.5.9.5 Brazil Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.5.9.6 Brazil Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
12.5.10 Argentina Medical Exoskeleton Market
12.5.10.1 Argentina Medical Exoskeleton Market Revenue and Forecasts to 2027 (US$ ‘000)
12.5.10.2 Argentina Medical Exoskeleton Market Revenue And Forecasts to 2027, By Drive Type (US$ ‘000)
12.5.10.3 Argentina Medical Exoskeleton Market Revenue And Forecasts to 2027, By Type (US$ ‘000)
12.5.10.4 Argentina Medical Exoskeleton Market Revenue And Forecasts to 2027, By Extremity (US$ ‘000)
12.5.10.5 Argentina Medical Exoskeleton Market Revenue And Forecasts to 2027, By Application (US$ ‘000)
12.5.10.6 Argentina Medical Exoskeleton Market Revenue And Forecasts to 2027, By End User (US$ ‘000)
13. Medical Exoskeleton Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies Done By Companies In the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.3.2 Product Launch
13.3.3 Approvals
13.3.4 Others Developments
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.4.2 Agreement
13.4.3 Partnership
13.4.4 Others Developments
14. Medical Exoskeleton Market–Key Company Profiles
14.1 Bioness Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Financial Overview
14.1.4 Product Portfolio
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 B-Temia Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Financial Overview
14.2.4 Product Portfolio
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 BIONIK Laboratories Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Financial Overview
14.3.4 Product Portfolio
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 CYBERDYNE INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Financial Overview
14.4.4 Product Portfolio
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Ekso Bionics Holdings, Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Financial Information
14.5.4 Product Portfolio
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 EXOATLET
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Financial Information
14.6.4 Product Portfolio
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 GOGOA Mobility Robots
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Financial Overview
14.7.4 Product Portfolio
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Hocoma AG
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Financial Overview
14.8.4 Product Portfolio
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Wearable Robotics srl
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 Product Portfolio
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Parker Hannifin Corporation
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Financial Overview
14.10.4 Product Portfolio
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 ReWalk Robotics
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Financial Overview
14.11.4 Product Portfolio
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 US Bionics, Inc.
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Financial Overview
14.12.4 Product Portfolio
14.12.5 SWOT Analysis
14.12.6 Key Developments
14.13 Tyromotion GmbH
14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Financial Overview
14.13.4 Product Portfolio
14.13.5 SWOT Analysis
14.13.6 Key Developments
15. Appendix
15.1 About The Publisher
15.2 Glossary of Terms

Companies mentioned

  • Bioness Inc.
  • B-Temia Inc.
  • BIONIK Laboratories Corp
  • CYBERDYNE INC
  • Ekso Bionics Holdings, Inc
  • EXOATLET
  • GOGOA Mobility Robots
  • Hocoma AG
  • Wearable Robotics srl
  • Parker Hannifin Corporation
  • ReWalk Robotics
  • US Bionics, Inc.
  • Tyromotion GmbH